Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders
Retinoic acid receptor-related orphan receptor γ-t (RORγt) and GPBAR1, a transmembrane G-protein-coupled receptor for bile acids, are attractive drug targets to develop clinically relevant small modulators as potent therapeutics for autoimmune diseases. Herein, we designed, synthesized, and evaluate...
Gespeichert in:
| Veröffentlicht in: | ACS omega 2023-02, Vol.8 (6), p.5983-5994 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5994 |
|---|---|
| container_issue | 6 |
| container_start_page | 5983 |
| container_title | ACS omega |
| container_volume | 8 |
| creator | Fiorillo, Bianca Roselli, Rosalinda Finamore, Claudia Biagioli, Michele di Giorgio, Cristina Bordoni, Martina Conflitti, Paolo Marchianò, Silvia Bellini, Rachele Rapacciuolo, Pasquale Cassiano, Chiara Limongelli, Vittorio Sepe, Valentina Catalanotti, Bruno Fiorucci, Stefano Zampella, Angela |
| description | Retinoic acid receptor-related orphan receptor γ-t (RORγt) and GPBAR1, a transmembrane G-protein-coupled receptor for bile acids, are attractive drug targets to develop clinically relevant small modulators as potent therapeutics for autoimmune diseases. Herein, we designed, synthesized, and evaluated several new bile acid-derived ligands with potent dual activity. Furthermore, we performed molecular docking and MD calculations of the best dual modulators in the two targets to identify the binding modes as well as to better understand the molecular basis of the inverse agonism of RORγt by bile acid derivatives. Among these compounds, 7 was identified as a GPBAR1 agonist (EC50 5.9 μM) and RORγt inverse agonist (IC50 0.107 μM), with excellent pharmacokinetic properties. Finally, the most promising ligand displayed robust anti-inflammatory activity in vitro and in vivo in a mouse model of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis. |
| doi_str_mv | 10.1021/acsomega.2c07907 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9933477</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2779343837</sourcerecordid><originalsourceid>FETCH-LOGICAL-a363t-9563de322d74c0f23f8468e968f2033f0e0a311df05e7ae40e3e731a1a20ed8a3</originalsourceid><addsrcrecordid>eNp1UcFO3DAQtaqigij3niofOTTU9gQ7uSBtl5autEC1omdrmoyXoCSmdoJET_0HPoX_6Ef0S-rVLis49DSjmffejN5j7J0UR1Io-RGr6Dta4pGqhCmFecX2VG5EJiGH18_6XXYQ440QQupCFUq_YbugC6m1KffYr9MmVv6Owj33jiO_SH3Lpy3GuBqcjtjys2-fJgvJJ0vfN3GIf38_LC4Xfx4HPusTMdJ2w50PfLgmfhUIh476YaUxm2fSZOdUNzhQzdNBH-rEe8t2HLaRDjZ1n33_8vlq-jWbX57NppN5hqBhyMpjDTWBUrXJK-EUuCLXBZW6cEoAOEECQcraiWMySLkgIAMSJSpBdYGwz07Wurfjj47qKr0VsLW3oekw3FuPjX256Ztru_R3tiwBcmOSwOFGIPifI8XBdsk0alvsyY_RKmPK5HMBK6hYQ6vgYwzktmeksKvU7FNqdpNaorx__t6W8JRRAnxYAxLV3vgx9Mmt_-v9A3JSpYY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2779343837</pqid></control><display><type>article</type><title>Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>American Chemical Society (ACS) Open Access</source><source>PubMed Central</source><creator>Fiorillo, Bianca ; Roselli, Rosalinda ; Finamore, Claudia ; Biagioli, Michele ; di Giorgio, Cristina ; Bordoni, Martina ; Conflitti, Paolo ; Marchianò, Silvia ; Bellini, Rachele ; Rapacciuolo, Pasquale ; Cassiano, Chiara ; Limongelli, Vittorio ; Sepe, Valentina ; Catalanotti, Bruno ; Fiorucci, Stefano ; Zampella, Angela</creator><creatorcontrib>Fiorillo, Bianca ; Roselli, Rosalinda ; Finamore, Claudia ; Biagioli, Michele ; di Giorgio, Cristina ; Bordoni, Martina ; Conflitti, Paolo ; Marchianò, Silvia ; Bellini, Rachele ; Rapacciuolo, Pasquale ; Cassiano, Chiara ; Limongelli, Vittorio ; Sepe, Valentina ; Catalanotti, Bruno ; Fiorucci, Stefano ; Zampella, Angela</creatorcontrib><description>Retinoic acid receptor-related orphan receptor γ-t (RORγt) and GPBAR1, a transmembrane G-protein-coupled receptor for bile acids, are attractive drug targets to develop clinically relevant small modulators as potent therapeutics for autoimmune diseases. Herein, we designed, synthesized, and evaluated several new bile acid-derived ligands with potent dual activity. Furthermore, we performed molecular docking and MD calculations of the best dual modulators in the two targets to identify the binding modes as well as to better understand the molecular basis of the inverse agonism of RORγt by bile acid derivatives. Among these compounds, 7 was identified as a GPBAR1 agonist (EC50 5.9 μM) and RORγt inverse agonist (IC50 0.107 μM), with excellent pharmacokinetic properties. Finally, the most promising ligand displayed robust anti-inflammatory activity in vitro and in vivo in a mouse model of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis.</description><identifier>ISSN: 2470-1343</identifier><identifier>EISSN: 2470-1343</identifier><identifier>DOI: 10.1021/acsomega.2c07907</identifier><identifier>PMID: 36816679</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>ACS omega, 2023-02, Vol.8 (6), p.5983-5994</ispartof><rights>2023 The Authors. Published by American Chemical Society</rights><rights>2023 The Authors. Published by American Chemical Society.</rights><rights>2023 The Authors. Published by American Chemical Society 2023 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a363t-9563de322d74c0f23f8468e968f2033f0e0a311df05e7ae40e3e731a1a20ed8a3</citedby><cites>FETCH-LOGICAL-a363t-9563de322d74c0f23f8468e968f2033f0e0a311df05e7ae40e3e731a1a20ed8a3</cites><orcidid>0000-0002-6170-279X ; 0000-0002-7532-6959 ; 0000-0002-0169-4441 ; 0000-0002-3025-5157 ; 0000-0002-4861-1199</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsomega.2c07907$$EPDF$$P50$$Gacs$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsomega.2c07907$$EHTML$$P50$$Gacs$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27080,27924,27925,53791,53793,56762,56812</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36816679$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fiorillo, Bianca</creatorcontrib><creatorcontrib>Roselli, Rosalinda</creatorcontrib><creatorcontrib>Finamore, Claudia</creatorcontrib><creatorcontrib>Biagioli, Michele</creatorcontrib><creatorcontrib>di Giorgio, Cristina</creatorcontrib><creatorcontrib>Bordoni, Martina</creatorcontrib><creatorcontrib>Conflitti, Paolo</creatorcontrib><creatorcontrib>Marchianò, Silvia</creatorcontrib><creatorcontrib>Bellini, Rachele</creatorcontrib><creatorcontrib>Rapacciuolo, Pasquale</creatorcontrib><creatorcontrib>Cassiano, Chiara</creatorcontrib><creatorcontrib>Limongelli, Vittorio</creatorcontrib><creatorcontrib>Sepe, Valentina</creatorcontrib><creatorcontrib>Catalanotti, Bruno</creatorcontrib><creatorcontrib>Fiorucci, Stefano</creatorcontrib><creatorcontrib>Zampella, Angela</creatorcontrib><title>Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders</title><title>ACS omega</title><addtitle>ACS Omega</addtitle><description>Retinoic acid receptor-related orphan receptor γ-t (RORγt) and GPBAR1, a transmembrane G-protein-coupled receptor for bile acids, are attractive drug targets to develop clinically relevant small modulators as potent therapeutics for autoimmune diseases. Herein, we designed, synthesized, and evaluated several new bile acid-derived ligands with potent dual activity. Furthermore, we performed molecular docking and MD calculations of the best dual modulators in the two targets to identify the binding modes as well as to better understand the molecular basis of the inverse agonism of RORγt by bile acid derivatives. Among these compounds, 7 was identified as a GPBAR1 agonist (EC50 5.9 μM) and RORγt inverse agonist (IC50 0.107 μM), with excellent pharmacokinetic properties. Finally, the most promising ligand displayed robust anti-inflammatory activity in vitro and in vivo in a mouse model of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis.</description><issn>2470-1343</issn><issn>2470-1343</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>N~.</sourceid><recordid>eNp1UcFO3DAQtaqigij3niofOTTU9gQ7uSBtl5autEC1omdrmoyXoCSmdoJET_0HPoX_6Ef0S-rVLis49DSjmffejN5j7J0UR1Io-RGr6Dta4pGqhCmFecX2VG5EJiGH18_6XXYQ440QQupCFUq_YbugC6m1KffYr9MmVv6Owj33jiO_SH3Lpy3GuBqcjtjys2-fJgvJJ0vfN3GIf38_LC4Xfx4HPusTMdJ2w50PfLgmfhUIh476YaUxm2fSZOdUNzhQzdNBH-rEe8t2HLaRDjZ1n33_8vlq-jWbX57NppN5hqBhyMpjDTWBUrXJK-EUuCLXBZW6cEoAOEECQcraiWMySLkgIAMSJSpBdYGwz07Wurfjj47qKr0VsLW3oekw3FuPjX256Ztru_R3tiwBcmOSwOFGIPifI8XBdsk0alvsyY_RKmPK5HMBK6hYQ6vgYwzktmeksKvU7FNqdpNaorx__t6W8JRRAnxYAxLV3vgx9Mmt_-v9A3JSpYY</recordid><startdate>20230214</startdate><enddate>20230214</enddate><creator>Fiorillo, Bianca</creator><creator>Roselli, Rosalinda</creator><creator>Finamore, Claudia</creator><creator>Biagioli, Michele</creator><creator>di Giorgio, Cristina</creator><creator>Bordoni, Martina</creator><creator>Conflitti, Paolo</creator><creator>Marchianò, Silvia</creator><creator>Bellini, Rachele</creator><creator>Rapacciuolo, Pasquale</creator><creator>Cassiano, Chiara</creator><creator>Limongelli, Vittorio</creator><creator>Sepe, Valentina</creator><creator>Catalanotti, Bruno</creator><creator>Fiorucci, Stefano</creator><creator>Zampella, Angela</creator><general>American Chemical Society</general><scope>N~.</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6170-279X</orcidid><orcidid>https://orcid.org/0000-0002-7532-6959</orcidid><orcidid>https://orcid.org/0000-0002-0169-4441</orcidid><orcidid>https://orcid.org/0000-0002-3025-5157</orcidid><orcidid>https://orcid.org/0000-0002-4861-1199</orcidid></search><sort><creationdate>20230214</creationdate><title>Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders</title><author>Fiorillo, Bianca ; Roselli, Rosalinda ; Finamore, Claudia ; Biagioli, Michele ; di Giorgio, Cristina ; Bordoni, Martina ; Conflitti, Paolo ; Marchianò, Silvia ; Bellini, Rachele ; Rapacciuolo, Pasquale ; Cassiano, Chiara ; Limongelli, Vittorio ; Sepe, Valentina ; Catalanotti, Bruno ; Fiorucci, Stefano ; Zampella, Angela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a363t-9563de322d74c0f23f8468e968f2033f0e0a311df05e7ae40e3e731a1a20ed8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fiorillo, Bianca</creatorcontrib><creatorcontrib>Roselli, Rosalinda</creatorcontrib><creatorcontrib>Finamore, Claudia</creatorcontrib><creatorcontrib>Biagioli, Michele</creatorcontrib><creatorcontrib>di Giorgio, Cristina</creatorcontrib><creatorcontrib>Bordoni, Martina</creatorcontrib><creatorcontrib>Conflitti, Paolo</creatorcontrib><creatorcontrib>Marchianò, Silvia</creatorcontrib><creatorcontrib>Bellini, Rachele</creatorcontrib><creatorcontrib>Rapacciuolo, Pasquale</creatorcontrib><creatorcontrib>Cassiano, Chiara</creatorcontrib><creatorcontrib>Limongelli, Vittorio</creatorcontrib><creatorcontrib>Sepe, Valentina</creatorcontrib><creatorcontrib>Catalanotti, Bruno</creatorcontrib><creatorcontrib>Fiorucci, Stefano</creatorcontrib><creatorcontrib>Zampella, Angela</creatorcontrib><collection>American Chemical Society (ACS) Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS omega</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fiorillo, Bianca</au><au>Roselli, Rosalinda</au><au>Finamore, Claudia</au><au>Biagioli, Michele</au><au>di Giorgio, Cristina</au><au>Bordoni, Martina</au><au>Conflitti, Paolo</au><au>Marchianò, Silvia</au><au>Bellini, Rachele</au><au>Rapacciuolo, Pasquale</au><au>Cassiano, Chiara</au><au>Limongelli, Vittorio</au><au>Sepe, Valentina</au><au>Catalanotti, Bruno</au><au>Fiorucci, Stefano</au><au>Zampella, Angela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders</atitle><jtitle>ACS omega</jtitle><addtitle>ACS Omega</addtitle><date>2023-02-14</date><risdate>2023</risdate><volume>8</volume><issue>6</issue><spage>5983</spage><epage>5994</epage><pages>5983-5994</pages><issn>2470-1343</issn><eissn>2470-1343</eissn><abstract>Retinoic acid receptor-related orphan receptor γ-t (RORγt) and GPBAR1, a transmembrane G-protein-coupled receptor for bile acids, are attractive drug targets to develop clinically relevant small modulators as potent therapeutics for autoimmune diseases. Herein, we designed, synthesized, and evaluated several new bile acid-derived ligands with potent dual activity. Furthermore, we performed molecular docking and MD calculations of the best dual modulators in the two targets to identify the binding modes as well as to better understand the molecular basis of the inverse agonism of RORγt by bile acid derivatives. Among these compounds, 7 was identified as a GPBAR1 agonist (EC50 5.9 μM) and RORγt inverse agonist (IC50 0.107 μM), with excellent pharmacokinetic properties. Finally, the most promising ligand displayed robust anti-inflammatory activity in vitro and in vivo in a mouse model of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>36816679</pmid><doi>10.1021/acsomega.2c07907</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-6170-279X</orcidid><orcidid>https://orcid.org/0000-0002-7532-6959</orcidid><orcidid>https://orcid.org/0000-0002-0169-4441</orcidid><orcidid>https://orcid.org/0000-0002-3025-5157</orcidid><orcidid>https://orcid.org/0000-0002-4861-1199</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2470-1343 |
| ispartof | ACS omega, 2023-02, Vol.8 (6), p.5983-5994 |
| issn | 2470-1343 2470-1343 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9933477 |
| source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; American Chemical Society (ACS) Open Access; PubMed Central |
| title | Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T09%3A19%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovery%20of%20a%20Novel%20Class%20of%20Dual%20GPBAR1%20Agonists%E2%80%93ROR%CE%B3t%20Inverse%20Agonists%20for%20the%20Treatment%20of%20IL-17-Mediated%20Disorders&rft.jtitle=ACS%20omega&rft.au=Fiorillo,%20Bianca&rft.date=2023-02-14&rft.volume=8&rft.issue=6&rft.spage=5983&rft.epage=5994&rft.pages=5983-5994&rft.issn=2470-1343&rft.eissn=2470-1343&rft_id=info:doi/10.1021/acsomega.2c07907&rft_dat=%3Cproquest_pubme%3E2779343837%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2779343837&rft_id=info:pmid/36816679&rfr_iscdi=true |